Stocksigma LogoStocksigma Logo

Strides Pharma Science Schedules Board Meeting to Approve Q2 Results

Strides Pharma Science Limited has scheduled a Board of Directors meeting on 29th Oct'26 to consider and approve the standalone and consolidated unaudited

Strides Pharma Science Schedules Board Meeting to Approve Q2 Results

Strides Pharma Science Ltd 路 Intimation 路 29 Oct 2026, 5:30 am

Strides Pharma Science Schedules Board Meeting to Approve Q2 Results Strides Pharma Science Limited has scheduled a Board of Directors meeting on 29th Oct'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for designated persons has been closed from 1st Oct'26 and will reopen 48 hours after the formal declaration of the financial results.

Original exchange filing (PDF)

More announcements from Strides Pharma Science Ltd

All Strides Pharma Science Ltd announcements